Chemical activators of Olr437 include a variety of compounds that influence different biochemical pathways leading to the activation of this protein. Forskolin, known for its ability to activate adenylate cyclase, results in an increased production of cyclic AMP (cAMP). The elevated cAMP levels activate protein kinase A (PKA), which can phosphorylate Olr437, thereby activating it. Similarly, Phorbol 12-myristate 13-acetate (PMA) is a potent activator of protein kinase C (PKC), a kinase that can also phosphorylate Olr437 as part of its signaling cascade. Ionomycin, a calcium ionophore, raises the intracellular calcium concentration, which can activate proteins sensitive to calcium, including Olr437 if it is part of the calcium signaling pathway. In the same vein, Thapsigargin functions by inhibiting the SERCA pump, leading to an increase in cytosolic calcium levels, which could activate Olr437 if it is responsive to calcium.
BAY K8644, an L-type calcium channel agonist, increases calcium influx, which can activate Olr437 if the protein is calcium-dependent. Zinc pyrithione elevates intracellular zinc levels, which can activate zinc-responsive proteins, potentially including Olr437. Okadaic acid and Calyculin A, both protein phosphatase inhibitors, lead to a general increase in phosphorylated proteins within the cell, which could result in the activation of Olr437 through increased phosphorylation. Anisomycin activates stress-activated protein kinases, which may phosphorylate and activate Olr437 within cellular stress response pathways. Ouabain disrupts ion gradients by inhibiting the Na+/K+ ATPase pump, which could trigger signal transduction pathways involving the activation of Olr437. Veratridine opens sodium channels, causing depolarization that may initiate signaling pathways involving Olr437. Lastly, H-89 dihydrochloride, a PKA inhibitor, can lead to the compensatory activation of proteins regulated by PKA, which may include Olr437 through complex feedback and regulatory mechanisms within the cell.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
Activates protein kinase C (PKC), which can phosphorylate and thus activate Olr437 as part of intracellular signaling cascades. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Increases intracellular calcium concentration, which can activate proteins that are calcium-sensitive, potentially including Olr437 if it responds to calcium signaling. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Inhibits the SERCA pump leading to increased cytosolic calcium levels, which can activate calcium-responsive proteins such as Olr437. | ||||||
(±)-Bay K 8644 | 71145-03-4 | sc-203324 sc-203324A sc-203324B | 1 mg 5 mg 50 mg | $82.00 $192.00 $801.00 | ||
Acts as an L-type calcium channel agonist, leading to increased intracellular calcium, which can activate Olr437 if it is calcium-sensitive. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $47.00 | ||
Increases intracellular zinc concentration, which can activate zinc-responsive proteins, potentially including Olr437. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $285.00 $520.00 $1300.00 | 78 | |
Inhibits protein phosphatases PP1 and PP2A, leading to increased phosphorylation levels of proteins, which can include Olr437, thus activating it. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A sc-24000B sc-24000C | 10 µg 100 µg 500 µg 1 mg | $160.00 $750.00 $1400.00 $3000.00 | 59 | |
Inhibits protein phosphatases, particularly PP1 and PP2A, leading to hyperphosphorylation and potential activation of Olr437. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $97.00 $254.00 | 36 | |
Activates stress-activated protein kinases, which can lead to the phosphorylation and activation of Olr437 within stress response pathways. | ||||||
Ouabain-d3 (Major) | sc-478417 | 1 mg | $506.00 | |||
Inhibits the Na+/K+ ATPase pump, leading to alterations in ion gradients that can activate signal transduction pathways involving Olr437. | ||||||
Veratridine | 71-62-5 | sc-201075B sc-201075 sc-201075C sc-201075A | 5 mg 10 mg 25 mg 50 mg | $80.00 $102.00 $197.00 $372.00 | 3 | |
Opens sodium channels, causing depolarization and potential activation of voltage-dependent signaling pathways that could include Olr437. | ||||||